Capital Fund Management S.A. Ligand Pharmaceuticals Inc Transaction History

Capital Fund Management S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$107.38 - $129.34 $92,561 - $111,491	-862 Reduced 29.3%	2,080 $237,000
Q2 2018 Aug 14, 2018	BUY	$150.77 - $207.98 $178,210 - $245,832	1,182 Added 67.16%	2,942 $609,000
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $243,988 - $321,411	1,760 New	1,760 $291,000

249

17.7M

61K

7.8K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.91B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Capital Fund Management S.A., based on Form 13F filings with the SEC.

Stay updated on Capital Fund Management S.A. with notifications on news.